GLA and Fabry disease: Although few studies have been published specifically describing ERT effects in female patients with FD [4,17,18,19], a direct comparison of agalsidase alfa ERT effectiveness between male and female patients using data from the Fabry Outcome Survey (FOS) showed “that women are as likely to respond to ERT as men” [20].